Both in Pharmaceuticals
Design Therapeutics vs Lexicon Pharmaceuticals
Over the past year DSGN returned +57.9% and LXRX returned +7.4%; their daily moves had a correlation of 0.19.
DSGN +57.9% LXRX +7.4%Growth of $1, one year, split-adjusted
| Metric | DSGN | LXRX |
|---|---|---|
| Price | $10.34 | $1.46 |
| Market cap | $647.1M | $649.6M |
| Today | +1.87% | +1.39% |
| 1 month | −16.7% | −16.1% |
| 6 months | −22.9% | −11.5% |
| Year to date | +10.2% | +27.0% |
| 1 year | +54.3% | +5.8% |
| Revenue growth (YoY) | — | −97.6% |
| Gross margin | — | 94.4% |
| Net margin | — | −4591.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 15.7× |
| Net cash | $207.4M | $139.2M |
| Dividend yield | — | — |
| Volatility (60d) | 55.2% | 51.9% |
| Short % of float | 21.8% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).